LSD1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of LSD1 monoclonal antibodies for the detection and analysis of lysine-specific demethylase 1 (LSD1). Multiple research applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LSD1 functions in regulating gene expression by demethylating lysine residues on histones, which influences chromatin structure and function. LSD1 is involved in numerous biological processes, including development, differentiation, and cellular response to stress. Research has shown that abnormal LSD1 activity is linked to various diseases, particularly cancer, highlighting its importance as a therapeutic target. Understanding LSD1's molecular mechanisms and cellular functions can provide valuable insights into disease pathways and potential treatments. Advanced research techniques and reliable detection methods are essential for studying LSD1's role in normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies for LSD1 enable researchers worldwide to advance their understanding of cellular processes and disease mechanisms, contributing to scientific progress in multiple fields.